Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules to be Selected for Guangdong Alliance Drug Collection_ Securities Times Network
Home > News > e company
Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules are to be selected for the Guangdong Alliance Drug Collection
2022-03-11 16:28
Source: Securities Times e Company
Author: Lee Jae-san
Securities Times · e company
Lee Jae-san
2022-03-11 16:28
Securities Times e Company News, Rundu Co., Ltd. (002923) announced on the evening of March 11, according to the announcement of the Guangdong Alliance Diclofenac and other drugs in the centralized and bulk procurement (the first batch) announced by the Guangdong Provincial Drug Trading Center. , the company’s product rabeprazole sodium enteric-coated capsules (registered trademark: Yutianqing) is planned to be selected for this centralized procurement.
Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.
4230266
Rundu Co., Ltd.: Rabeprazole Sodium Enteric-Coated Capsules are to be selected for the Guangdong Alliance Drug Collection
6885
e company
news
1445
Lee Jae-san
2022-03-11